UnitedHealth Group Incorporated(UNH)
Medical - Healthcare Plans · Eden Prairie, MN
$393.06-7.78 (-1.94%)
Delayed quote: Sep 9, 2026, 4:00 PM EDT
Medical - Healthcare Plans · Eden Prairie, MN
Delayed quote: Sep 9, 2026, 4:00 PM EDT
Trailing-twelve-month (TTM) revenue is $450.13 Billion with a year-over-year growth of +6.46%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $113,161,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $113,215,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $111,721,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $112,032,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $450,129,000,000 |
Current P/S: $356,955,239,436 market capitalization ÷ $450,129,000,000 TTM revenue = 0.79x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $112.03B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Intersegment Eliminations | -$64.6B | -$80.0B | -$90.9B | -$108.3B | -$150.9B | N/A |
| Optumhealth | $30.3B | $39.8B | $54.1B |
$450.13B
$450.13 Billion
+6.46%
vs. $422.82B a year ago (TTM)
+10.59%
5 Year compound annual growth rate
1 Year
+6.46%
3 Year
+8.90%
5 Year
+10.59%
10 Year
+9.84%
15 Year
+10.67%
20 Year
+10.68%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $447.57B | +$47.29B | +11.81% |
| 2024 | $400.28B | +$28.66B | +7.71% |
| 2023 | $371.62B | +$47.46B | +14.64% |
| 2022 | $324.16B | +$36.56B | +12.71% |
| 2021 | $287.60B | +$30.46B | +11.84% |
| 2020 |
TTM Growth
+6.46%
3-Year CAGR
+8.90%
5-Year CAGR
+10.59%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
| $105.4B |
| $19.8B |
| Optuminsight | $10.0B | $10.8B | $12.2B | $14.6B | $18.8B | N/A |
|---|
| Optumrx | $74.3B | $87.5B | $91.3B | $99.8B | $133.2B | N/A |
|---|
| Unitedhealthcare | $193.8B | $200.9B | $222.9B | $249.7B | $298.2B | $332.4B |
|---|
| $257.14B |
| +$14.99B |
| +6.19% |
| 2019 | $242.16B | +$15.91B | +7.03% |
| 2018 | $226.25B | +$25.09B | +12.47% |
| 2017 | $201.16B | +$16.32B | +8.83% |
| 2016 | $184.84B | +$27.73B | +17.65% |